IND submission is a major milestone in the life of your drug. We can provide all supporting analytical data to help ensure a smooth application process.
We have the expertise, flexibility, and resources to provide a full range of pharmaceutical API custom development services at every stage of the lifecycle.
We can provide lab-, kilo- and pilot-scale manufacturing for preclinical studies and all phases of clinical trials, supplying milligram to kilogram quantities.
Cambrex brings more than 40 years of generic API manufacturing experience to its pharmaceutical partners. From our sites in Italy, Sweden, and the USA, we are a leading global supplier of generic APIs.
Drug substance tech transfer sounds so simple on the surface, but it’s a complex activity carrying a number of technical, regulatory, and quality risks.
At Snapdragon Chemistry, now part of Cambrex, our chemists specialize in creating custom solutions and technologies to take on your toughest process development and production challenges. This includes expertise in designing and building reactors that enable seamless technology transfer as a process scales up for commercial manufacturing.
At Cambrex, we provide a range of technologies equipped to solve your API manufacturing challenges, and we are flexible enough to handle the most complex molecules.
You can rely on our extensive portfolio of analytical development solutions and testing services to rapidly advance your molecule for the greatest chance of success.
We’re solid state chemistry experts who can deliver timely, phase-appropriate solutions to optimize the physical stability of your API, develop a more bioavailable formulation or overcome other challenges.
Cambrex’s experienced analysts are well-equipped to ensure microbial testing is of the highest quality for our customers and delivered with a quick and reliable turnaround.
Cambrex and Q1 Scientific’s stability storage and sample management capabilities provide a variety of pharmaceutical storage conditions, with walk-in and reach-in chambers that meet all ICH Q1A requirements.
Cambrex offers extensive development services tailored to meet your drug product needs in early development. From pre-formulation to Phase II, we ensure your products are developed with speed, flexibility, and quality in mind.
Whether you need rapid development, flexible manufacturing solutions, or high-quality production, Cambrex is your trusted partner for advancing your drug product from concept to the clinic.
Cambrex is here to support you in early-phase development. Our development experts apply their ingenuity and skill to address your unique challenges.
Our teams of creative problem-solvers work closely with you to accelerate drug development timelines, optimize processes, and meet regulatory requirements.
We understand that the commercial phase of drug development can be challenging, especially when it comes to manufacturing at scale and meeting changing market demands.
Cambrex is a leading global supplier of more than 70 generic APIs, as well as intermediates and derivatives.
The investigational new drug (IND) application is a major milestone in the life of your drug. According to the Food and Drug Administration (FDA), an IND submission must include animal pharmacology and toxicology studies, manufacturing information, clinical protocols and investigator information.
Through our site in Longmont, CO, Cambrex offers full CMC support for your IND application, from process chemistry and drug substance manufacturing all the way through formulation development and drug product manufacturing. Throughout the entire process, our analytical team provides quality analysis of your program to ensure you meet your milestones. With process chemistry, drug product and analytical experts collaborating under the same roof, we ensure that your molecule has its best chance at success.
To help you meet strict IND requirements and accelerate the filing process, we provide all supporting analytical data (specifications and release data) for raw materials, intermediates and APIs. We also provide all master batch records, as well as a certificate of GMP stating that we manufacture our APIs according to industry standards.
Our IND enabling services include:
Looking for a partner that balances passion with painstaking attention to detail? Speak to one of our experts about how we can help you meet IND requirements and prepare for in-human trials.
Rigorous, effective analytical testing is key in the drug development lifecycle. Because this testing is used to verify control of drug chemistry, it can help identify barriers that prevent movement to the next phase in the development process. That’s why it’s critical to have efficient, accurate and high-quality analytical support for your testing requirements.
Despite the evolving landscape, the success rate for drug candidates during early development continues to be low. However, when you understand the pitfalls that can impede early development, the associated risks can be effectively managed, ultimately driving your program and your organization toward long-term commercial success.
When preparing for IND submission, drug developers must carefully consider multiple components of their program: analytical challenges, manufacturing and engineering controls, delivery systems, and more. Watch this webinar to see Cambrex experts discuss tips for optimizing your early development program